Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-905-0 | CAS number: 111-76-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 98 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 091 mg/m³
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: see discussion below and attached documentation to this record
- Overall assessment factor (AF):
- 9
- Modified dose descriptor starting point:
- LOAEC
- Value:
- 9 824 mg/m³
- Explanation for the modification of the dose descriptor starting point:
An acute inhalation DNEL needs to be derived as the substance is classified for acute toxicity by the inhalation route. No suitable data is available, therefore a value for the systemic route therefore a value is derived by route to route extrapolation from the a LOAEL is based on the data from human poisoning incidents by the oral route. Of those values reported, the lowest estimated dose was 400mg/kg, which produced adverse but reversible symptoms. Route to route extrapolation can then be performed as shown:
Assume 5m3 inhaled over 4hrs exposure - half of normal workday exposure estimate of 10m3 over 8hrs, table R.8 -2, 57% absorption efficiency, 70kg worker = 9824mg/m3. (=400x70/5/0.57) (Inhalation absorption efficiency based on work of Johansson, 1986 - see chapter 7.1.1) Note that the theoretical inhalation figure used as the starting poin is above the saturated vapour concentration.
- AF for dose response relationship:
- 3
- Justification:
- LOAEL to NOAEL extrapolation
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- not required, human data
- AF for other interspecies differences:
- 1
- Justification:
- not required, human data
- AF for intraspecies differences:
- 3
- Justification:
- See document attached to this record.
- AF for the quality of the whole database:
- 1
- Justification:
- default
- AF for remaining uncertainties:
- 1
- Justification:
- default
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 246 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
- Route of original study:
- Dermal
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 59 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 426 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- DNEL derivation method:
- other: see discussion below and attached documentation to this record
- Overall assessment factor (AF):
- 15
- Modified dose descriptor starting point:
- LOAEC
- Value:
- 12 760 mg/m³
- Explanation for the modification of the dose descriptor starting point:
An acute inhalation DNEL needs to be derived as the substance is classified for acute toxicity by the inhalation route. No suitable data is available, therefore a value for the systemic route therefore a value is derived by route to route extrapolation from the a LOAEL is based on the data from human poisoning incidents by the oral route. Of those values reported, the lowest estimated dose was 400mg/kg, which produced adverse but reversible symptoms. Route to route extrapolation can then be performed as shown:
Assume 3.33m3 inhaled over 4hrs exposure - one sixth of consumer exposure estimate of 20m3 over 24hrs, table R-8.2, 57% absorption efficiency, 60kg consumer = 12760mg/m3. (=400x60/3.3/0.57) (Inhalation absorption efficiency based on work of Johansson, 1986 - see chapter 7.1.1) Note that this starting point is well in excess of the saturated vapour concentration.
- AF for dose response relationship:
- 3
- Justification:
- LOAEL->NOAEL
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- not required, human data
- AF for other interspecies differences:
- 1
- Justification:
- not required, human data
- AF for intraspecies differences:
- 5
- Justification:
- See attached document
- AF for the quality of the whole database:
- 1
- Justification:
- default
- AF for remaining uncertainties:
- 1
- Justification:
- default
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 147 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6.3 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- other: see discussion below and attached documentation to this record
- Overall assessment factor (AF):
- 10.9
- Modified dose descriptor starting point:
- LOAEL
- Value:
- 69 mg/kg bw/day
- AF for dose response relationship:
- 3
- Justification:
- LOAEL to NOAEL. There is evidence to suggest that the NOAEL is only a little less than the LOAEL
- AF for differences in duration of exposure:
- 1
- Justification:
- No factor is used for study length as the data shows that the severity of effect does not increase from 90 days to lifetime exposure.
- AF for interspecies differences (allometric scaling):
- 7.2
- Justification:
- For the oral route, the LOAEL (69mg/kg from the NTP key repeat dose oral study in mice - see chapter 7.5.1) is equivalent to a human dose of 9.5mg/kg (based on extrapolation using the PBPK model - see chapter 7.1.1 of IUCLID). This accounts for toxicokinetic effects. This is converted into an allometric scaling factor of 7.25
- AF for other interspecies differences:
- 0.1
- Justification:
- based on lower sensitivity of humans to key effect of haemolysis. See IUCLID chapter 7.9.3.
- AF for intraspecies differences:
- 5
- Justification:
- See document attached to this record
- AF for the quality of the whole database:
- 1
- Justification:
- default
- AF for remaining uncertainties:
- 1
- Justification:
- default
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 26.7 mg/kg bw/day
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: see discussion below and attached documentation to this record
- Overall assessment factor (AF):
- 15
- Modified dose descriptor starting point:
- LOAEL
- Value:
- 400 mg/kg bw/day
- AF for dose response relationship:
- 3
- Justification:
- LOAEL to NOAEL
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- not required, human data
- AF for other interspecies differences:
- 1
- Justification:
- not required, human data
- AF for intraspecies differences:
- 5
- Justification:
- See document attached to this record
- AF for the quality of the whole database:
- 1
- Justification:
- default
- AF for remaining uncertainties:
- 1
- Justification:
- default
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.